Oncology Voice Network
Join to access to all OVN content. Join for Free
The Augmented MSL
Artificial Intelligence in MSL AI tools in healthcare generative AI in medicine Pfizer AI integration MSL productivity AI

The Augmented MSL

  • Oct 15th 2024
  • 35 mins
  • E227

Share This Article

Summary

This week's guest is Nandini Sabharwal, Director, Migraine and Women's Health, Field Medical Group at Pfizer and we discuss the role of artificial intelligence in every day MSL life.

Key Points

  • Embracing AI can significantly reduce preparation time for MSLs by providing quick, insightful answers and aiding in role-specific tasks such as healthcare provider meeting prep and advisory board planning.
  • Effective use of generative AI tools like ChatGPT or Microsoft Copilot requires learning how to craft detailed, specific prompts and understanding the limitations of these tools, including the necessity of refining the output manually.
  • Company buy-in and licensing are crucial for integrating AI tools into daily workflows, and while the initial learning curve can be steep, the productivity gains and potential for improved communication make it a worthwhile investment for MSLs.

Click for Source
Artificial Intelligence in MSL, AI tools in healthcare, generative AI in medicine, Pfizer AI integration, MSL productivity AI

Related Topics

See More Topics

Meet Our Innovation Partners

You May Also Like

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Feb 23rd • 8 mins • read
Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Feb 22nd • 10 mins • read
Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Feb 11th • 4 mins • read
Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Sep 3rd • 1 min • read
Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Sep 9th • 5 mins • read
Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Dec 2nd • 2 mins • read

Explore OVN

Articles Expert-written insights
Browse Topics Oncology focus areas
OVN Podcast Flagship show
Community Why join OVN